AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis
Authors: Mi, JQ Blanc-Jouvan, F Wang, J Sotto, MF Cousin, F Castinel, A Chauvet, M Sotto, JJ Polack, B Mossuz, P
Citation: Jq. Mi et al., Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis, J HEMATH ST, 10(3), 2001, pp. 405-409
Novel evidence of a role for chromosome I pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma
Authors: Le Baccon, P Leroux, D Dascalescu, C Duley, S Marais, D Esmenjaud, E Sotto, JJ Callanan, M
Citation: P. Le Baccon et al., Novel evidence of a role for chromosome I pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma, GENE CHROM, 32(3), 2001, pp. 250-264
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group
Authors: Jourdan, E Reiffers, J Stoppa, AM Sotto, JJ Attal, M Bouabdallaha, R Marit, G Fegueux, N Boulat, O Dastugue, N Boiron, JM Faberes, C Gastaut, JA Maraninchi, D Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
Authors: Garban, F Attal, M Rossi, JF Payen, C Fegueux, N Sotto, JJ
Citation: F. Garban et al., Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation, LEUKEMIA, 15(4), 2001, pp. 642-646
In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation
Authors: Roucard, C Thomas, C Pasquier, MA Trowsdale, J Sotto, JJ Neefjes, J van Ham, M
Citation: C. Roucard et al., In vivo and in vitro modulation of HLA-DM and HLA-DO is induced by B lymphocyte activation, J IMMUNOL, 167(12), 2001, pp. 6849-6858
Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilutionassays
Authors: Bonnefoix, T Bonnefoix, P Callanan, M Verdiel, P Sotto, JJ
Citation: T. Bonnefoix et al., Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilutionassays, J IMMUNOL, 167(10), 2001, pp. 5725-5730
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
Authors: Blaise, D Maraninchi, D Michallet, M Reiffers, J Jouet, JP Milpied, N Devergie, A Attal, M Sotto, JJ Kuentz, M Ifrah, N Duriac, C Bordigoni, P Gratecos, N Guilhot, F Guyotat, D Gluckman, E Vernant, JP
Citation: D. Blaise et al., Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission, BLOOD, 97(11), 2001, pp. 3669-3671
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
Authors: Chaperot, L Bendriss, N Manches, O Gressin, R Maynadie, M Trimoreau, F Orfeuvre, H Corront, B Feuillard, J Sotto, JJ Bensa, JC Briere, F Plumas, J Jacob, MC
Citation: L. Chaperot et al., Identification of a leukemic counterpart of the plasmacytoid dendritic cells, BLOOD, 97(10), 2001, pp. 3210-3217
Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission
Authors: Blaise, D Attal, M Reiffers, J Michallet, M Bellanger, C Pico, JL Stoppa, AM Payen, C Marit, G Bouabdallah, R Sotto, JJ Rossi, JF Brandely, M Hercend, T Maraninchi, D
Citation: D. Blaise et al., Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission, EUR CYTOKIN, 11(1), 2000, pp. 91-97
Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma
Authors: Chaperot, L Chokri, M Jacob, MC Drillat, P Garban, F Egelhofer, H Molens, JP Sotto, JJ Bensa, JC Plumas, J
Citation: L. Chaperot et al., Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma, LEUKEMIA, 14(9), 2000, pp. 1667-1677
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line
Authors: Irisarri, M Plumas, J Bonnefoix, T Jacob, MC Roucard, C Pasquier, MA Sotto, JJ Lajmanovich, A
Citation: M. Irisarri et al., Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line, LEUKEMIA, 14(12), 2000, pp. 2149-2158
Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
Authors: Michallet, M Thomas, X Vernant, JP Kuentz, M Socie, G Esperou-Bourdeau, H Milpied, N Blaise, D Rio, B Reiffers, J Jouet, JP Cahn, JY Bourhis, JH Lioure, B Leporrier, M Sotto, JJ Souillet, G Sutton, L Bordigoni, P Dreyfus, F Tilly, H Gratecos, N Attal, M Leprise, PY Demeocq, F Michel, G Buzyn, A Delmas-Marsalet, B Bernaudin, F Ifrah, N Sadoun, A Guyotat, D Cavazzana-Cavo, M Caillot, D De Revel, T Vannier, JP Baruchel, A Fegueux, N Tanguy, ML Thiebaut, A Belhabri, A Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
The IgG Fc receptor, Fc gamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma (vol 97, pg 309, 2000)
Authors: Callanan, MB Le Baccon, P Mossuz, P Duley, S Bastard, C Hamoudi, R Dyer, MJ Klobeck, G Rimokh, R Sotto, JJ Leroux, D
Citation: Mb. Callanan et al., The IgG Fc receptor, Fc gamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma (vol 97, pg 309, 2000), P NAS US, 97(15), 2000, pp. 8745-8745
The IgG Fc receptor, Fc gamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
Authors: Callanan, MB Le Baccon, P Mossuz, P Duley, S Bastard, C Hamoudi, R Dyer, MJ Klobeck, G Rimokh, R Sotto, JJ Leroux, D
Citation: Mb. Callanan et al., The IgG Fc receptor, Fc gamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma, P NAS US, 97(1), 2000, pp. 309-314
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
Authors: de Botton, S Chevret, S Sanz, M Dombret, H Thomas, X Guerci, A Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Geiser, K Hess, U Maloisel, F Castaigne, S Preudhomme, C Chomienne, C Degos, L Fenaux, P
Citation: S. De Botton et al., Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, BR J HAEM, 111(3), 2000, pp. 801-806
The reduction of in vitro radiation-induced Fas-related apoptosis in CD34(+) progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34(+) cell proliferation and differentiation
Authors: Drouet, M Mathieu, J Grenier, N Multon, E Sotto, JJ Herodin, F
Citation: M. Drouet et al., The reduction of in vitro radiation-induced Fas-related apoptosis in CD34(+) progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34(+) cell proliferation and differentiation, STEM CELLS, 17(5), 1999, pp. 273-285
Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma
Authors: Jacob, MC Agrawal, S Chaperot, L Giroux, C Gressin, R Le Marc'Hadour, F Favre, M Sotto, JJ Bensa, JC Plumas, J
Citation: Mc. Jacob et al., Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma, LEUKEMIA, 13(9), 1999, pp. 1428-1433
Lack of efficacy of clarithromycin in advanced multiple myeloma
Authors: Moreau, P Huynh, A Facon, T Bouilly, I Sotto, JJ Legros, L Milpied, N Attal, M Bataille, R Harousseau, JL
Citation: P. Moreau et al., Lack of efficacy of clarithromycin in advanced multiple myeloma, LEUKEMIA, 13(3), 1999, pp. 490-491
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas
Authors: Chaperot, L Delfau-Larue, MH Jacob, MC Molens, JP Roussel, B Agrawal, S Farcet, JP Gressin, R Sotto, JJ Bensa, JC Plumas, J
Citation: L. Chaperot et al., Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas, EXP HEMATOL, 27(7), 1999, pp. 1185-1193
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas
Authors: Chaperot, L Plumas, J Jacob, MC Bost, F Molens, JP Sotto, JJ Bensa, JC
Citation: L. Chaperot et al., Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas, EXP HEMATOL, 27(3), 1999, pp. 479-488
Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation
Authors: Dascalescu, CM Callanan, M Chauvet, M Le Baccon, P Pegourie-Bandelier, B Garban, F Sotto, JJ Leroux, D
Citation: Cm. Dascalescu et al., Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation, BONE MAR TR, 23(7), 1999, pp. 687-694
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation
Authors: Michallet, M Perrin, MC Belhabri, A Molina, L Nicolini, F Tigaud, JD Sotto, JJ Guyotat, D Fiere, D Archimbaud, E
Citation: M. Michallet et al., Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 145-150
Deletion 7q in B-cell low-grade lymphoid malignancies: A cytogenetic/fluorescence in situ hybridization and immunopathologic study
Authors: Dascalescu, CM Peoc'h, M Callanan, M Jacob, MC Sotto, MF Gressin, R Sotto, JJ Leroux, D
Citation: Cm. Dascalescu et al., Deletion 7q in B-cell low-grade lymphoid malignancies: A cytogenetic/fluorescence in situ hybridization and immunopathologic study, CANC GENET, 109(1), 1999, pp. 21-28
Role of autologous CD4(+) T cell clones in human B non-Hodgkin's lymphoma:aborted activation and G1 blockade induced by cell-cell contact
Authors: Martin, I Bonnefoix, T Roucard, C Perron, P Lajmanovich, A Moine, A Leroux, D Sotto, JJ Garban, F
Citation: I. Martin et al., Role of autologous CD4(+) T cell clones in human B non-Hodgkin's lymphoma:aborted activation and G1 blockade induced by cell-cell contact, EUR J IMMUN, 29(10), 1999, pp. 3188-3195
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
Authors: Fenaux, P Chastang, C Chevret, S Sanz, M Dombret, H Archimbaud, E Fey, M Rayon, C Huguet, F Sotto, JJ Gardin, C Makhoul, PC Travade, P Solary, E Fegueux, N Bordessoule, D San Miguel, J Link, H Desablens, B Stamatoullas, A Deconinck, E Maloisel, F Castaigne, S Preudhomme, C Degos, L
Citation: P. Fenaux et al., A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia, BLOOD, 94(4), 1999, pp. 1192-1200
Risultati: 1-25 | 26-26